EHDS Sandbox

Emergency overview · Uppsala → Paris, and back

Andrea Lindqvist

Born 2002-07-25 · personnummer 200207252388

Source: Vårdcentralen Norrskogen · document dated 2026-08-24 · written in en

Loaded into the sandbox's FHIR server: 27 resources. Patient · document

Critical: read before acting

  • Medicine · ATC A10AE06 Insulin degludec 100 units/mL solution for injection · 26 units subcutaneously once daily at bedtime since 2019-01-14

    Insulin: never stop abruptly; risk of ketoacidosis

  • Medicine · ATC A10AB05 Insulin aspart 100 units/mL solution for injection · 4-8 units subcutaneously with each main meal, adjusted to carbohydrate intake and pre-meal glucose since 2019-01-14

    Insulin: never stop abruptly; risk of ketoacidosis

  • Medicine · ATC N06BA12 Lisdexamfetamine 50 mg capsule · 1 capsule (50 mg) by mouth each morning since 2021-03-02

    Controlled stimulant Lisdexamfetamine is a controlled stimulant. In France it needs a specialist and a secure prescription of at most 28 days, so a Swedish ePrescription cannot simply be dispensed in Paris.

  • Condition Type 1 diabetes mellitus · active since 2012-09-04

Out of date, cancelled or missing

  • Missing Last dose not recorded: Insulin degludec 100 units/mL solution for injection

    The list says what is prescribed, not what was taken or when.

  • Missing Last dose not recorded: Insulin aspart 100 units/mL solution for injection

    The list says what is prescribed, not what was taken or when.

  • Missing Last dose not recorded: Lisdexamfetamine 50 mg capsule

    The list says what is prescribed, not what was taken or when.

  • Silent signal Cancelled, not rebooked: Digital follow-up with diabetes specialist nurse, Uppsala - every 3 months 2019-01-14

    The plan is still marked active but its activity was cancelled. Nobody was told.

  • Out of date Newest lab result is 10 months old 2025-12-09

    Complete and well coded is not the same as current.

2 items held back: restricted category

The patient has restricted access to mental-health data (EHDS Art. 8 and 11). In an emergency a clinician may open it for the patient's vital interests. The access is logged and the patient can see it.

Background

Allergies

  • No known allergies or intolerances

    Stated positively by the source, not merely absent.

Medicines

  • Sertraline 50 mg tablet · 1 tablet (50 mg) by mouth once daily · completed 2021-11-20

Problems

  • Attention deficit hyperactivity disorder · active 2015-02-11

Results

  • Hemoglobin A1c/Hemoglobin.total standardized per IFCC-RMP for CDT in Blood · 68 mmol/mol 2025-12-09
  • Creatinine [Moles/volume] in Serum or Plasma · 71 umol/L 2025-12-09
  • Albumin/Creatinine [Ratio] in Urine · 4.1 mg/mmol 2025-12-09
  • Cholesterol [Moles/volume] in Serum or Plasma · 4.4 mmol/L 2025-12-09

Devices

  • Continuous glucose monitoring system

Labels are shown as the source wrote them; translation is not applied yet.

← Back to the scenario